Life Science Company News

Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Read more ››
By: GlobeNewswire - 22 May 2024

Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

Read more ››
By: GlobeNewswire - 22 May 2024

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Read more ››
By: GlobeNewswire - 22 May 2024

Equitable access to treatment must keep pace with latest advances in reproductive surgery

Read more ››
By: PR Newswire Association LLC. - 22 May 2024

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016

Read more ››
By: PR Newswire Association LLC. - 22 May 2024

GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services

Read more ››
By: PR Newswire Association LLC. - 22 May 2024

Novo Nordisk Foundation and Technical University of Denmark press release: Bacteria in our gut could play a role in cardiometabolic disease: A new initiative aims to find out

Read more ››
By: PR Newswire Association LLC. - 22 May 2024

Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

Read more ››
By: GlobeNewswire - 22 May 2024

APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 for the Diagnosis of Progressive Supranuclear Palsy

Read more ››
By: GlobeNewswire - 22 May 2024

Advanced Waste Management Solution for Hospitals

Read more ››
By: PR Newswire Association LLC. - 22 May 2024

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

Read more ››
By: GlobeNewswire - 21 May 2024

Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update

Read more ››
By: GlobeNewswire - 21 May 2024

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)

Read more ››
By: GlobeNewswire - 21 May 2024

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Read more ››
By: GlobeNewswire - 21 May 2024

Trinity Biotech plc to Announce Q1 2024 Financial Results

Read more ››
By: GlobeNewswire - 21 May 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 21 May 2024

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

Read more ››
By: GlobeNewswire - 21 May 2024

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth

Read more ››
By: GlobeNewswire - 21 May 2024

Atrion Corporation Declares Quarterly Cash Dividend

Read more ››
By: GlobeNewswire - 21 May 2024

BioCardia Announces Reverse Stock Split

Read more ››
By: GlobeNewswire - 21 May 2024
Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Enhance your business development with Biotechgate